EcoDrugPlus

Heat Shock Protein Hsp 90-Alpha

Ensembl ID : ENSSFOG00015000997
Gene Symbol: LOC108930816
3 Cross references
345 Possible Orthologues:

Hepatocyte Growth Factor Receptor-Like

Ensembl ID : ENSSFOG00015013423
Gene Symbol: LOC108931650
3 Cross references
204 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSSFOG00015004653
Gene Symbol: LOC108936270
3 Cross references
511 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSSFOG00015001587
Gene Symbol: HRH1
3 Cross references
186 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSSFOG00015004470
Gene Symbol: HRH2A
1 Cross references
182 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSSFOG00015025218
Gene Symbol: HDAC11
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSSFOG00015021171
Gene Symbol: HDAC2
3 Cross references
209 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSSFOG00015009015
Gene Symbol: HDAC4
1 Cross references
260 Possible Orthologues:

Histone Deacetylase 4-Like

Ensembl ID : ENSSFOG00015016138
Gene Symbol: LOC108928218
3 Cross references
260 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSSFOG00015009531
Gene Symbol: HDAC5
1 Cross references
196 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSSFOG00015001196
Gene Symbol: HDAC6
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSSFOG00015018601
Gene Symbol: HDAC7
3 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).